Homeocrelizumab

  • NICE rejects Ocrevus for PPMS, citing cost concerns

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE approves Ocrevus in RRMS but with certain conditions

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Genentech to Present New Data for Ocrevus and NS pipeline expansion at AAN

    • April 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE denies Ocrelizumab for RRMS in UK

    • April 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more